Matthew R. Zibelman
Papers
1
Total Citations
2
H-Index
1
About
Matthew R. Zibelman is a urologic oncologist whose research centers on the clinical management and outcomes of bladder cancer, particularly urothelial carcinoma. His work critically examines how indeterminate pulmonary nodules discovered during staging for radical cystectomy influence patient prognosis and treatment pathways. In his most cited study, published in the *Journal of Urology*, Zibelman and colleagues investigated the clinical destiny of such nodules, providing essential data to guide decision-making in a common yet uncertain clinical scenario. This contribution helps clarify whether these incidental findings represent metastatic disease or benign processes, directly impacting surgical and oncologic planning. While his citation metrics are modest, the work addresses a high-stakes diagnostic challenge in bladder cancer care. Zibelman’s research, often conducted in collaboration with experts like Elizabeth Plimack and Daniel Geynisman, underscores a commitment to refining risk stratification and improving outcomes for patients undergoing aggressive treatment for invasive bladder cancer.
Research Focus
Key Achievements
Top Papers
- 1